Back to search
Resistant Epilepsy, Drug
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Resistant Epilepsy, Drug trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Resistant Epilepsy, Drug trials you may qualify forDravet Syndrome (DS) is a severe neurodevelopmental disease, which is predominantly caused by mutations of SCN1A, the gene coding for Nav1.1 voltage-gated sodiu…
The aim of the MicroEPI study is to know whether it is possible to use safely a medical device (a micro-electrode) that allows recording the activity of neurons…
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Background: \- The blood-brain barrier separates the brain from the rest of the body. Epilepsy is a neurological disease that causes seizures. It can affect th…
This is an exploratory clinical trial (Protocol: UX-GIP001-101) investigating UX-GIP001 Injection, a novel cell therapy product consisting of human GABAergic in…
This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures
Epilepsy is a common disease affecting 0.5 to 1% of the general population. Epilepsies refractory to drug treatment lead to increased morbidity, mortality and h…
This project aims to conduct a pilot study based on the targeting of the epileptogenic zone previously localized very precisely by stereoelectroencephalography…
Transcranial current stimulation (tCS), a safe, tolerable technique employing weak currents (\~ 1 mA) applied to the scalp, has been shown to be a promising tec…